Key facts
- It has raised $20.2M; the latest was Accelerator/Incubator in May 2024.
- Notable investors include Plug and Play Tech Center, MedTech Innovator, Innovestor, Maki.vc, Start Capital — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for CardioSignal
- ·The full record, as it builds
Funding rounds
No funding rounds for CardioSignal are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CardioSignal
Developer of a digital cardiac biomarker designed for self-monitoring, remote care, and point-of-care diagnostics. The company's software provides features such as atrial fibrillation detection, vitals and heart physiology, measurement history, insights and news feed, measurement reminders and more, enabling clients to prevent strokes and heart attacks and improve outcomes.
- Sector
- Healthcare
- HQ
- Turku, Finland
- Founded
- 2016
- Employees
- 30
- Website
- cardiosignal.com/
- Ownership
- Privately Held (backing)
CardioSignal doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CardioSignal shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CardioSignal in its N-PORT filings yet. We sweep new filings monthly.